CIRRX | RAAAX | CIRRX / RAAAX | |
Total Expense Ratio | 1.25 | 2.80 | 45% |
Annual Report Gross Expense Ratio | 1.25 | 2.96 | 42% |
Fund Existence | 11 years | 12 years | - |
Gain YTD | 5.434 | -19.807 | -27% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 37M | 22,443% |
Annual Yield % from dividends | 2.37 | 1.41 | 168% |
Returns for 1 year | -2.06 | -22.03 | 9% |
Returns for 3 years | 24.03 | -21.03 | -114% |
Returns for 5 years | 29.91 | -48.59 | -62% |
Returns for 10 years | 59.74 | -8.28 | -722% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 72.17 | 1.04 | +1.46% |
Janus Henderson Global Life Sciences A | |||
JEVNX | 11.06 | 0.03 | +0.27% |
JHancock Disciplined Value Em Mkts EqNAV | |||
RICCX | 66.95 | 0.09 | +0.13% |
American Funds Invmt Co of Amer R3 | |||
KLCCX | 12.27 | N/A | N/A |
Federated Hermes Kaufmann Large Cap C | |||
FEQDX | 14.68 | N/A | N/A |
Fidelity Advisor Hedged Equity C |